David F McDermott

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Regulatory T Cells

Monoclonal Antibody

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

David J Einstein, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan
Reply to B. Tombal et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wenxin Xu, Valerie Gaborieau, Samuel M Niman, Anush Mukeriya, Xiaowen Liu, Krishna P Maremanda, Ayumi Takakura, David Zaridze, Matthew L Freedman, Wanling Xie, David F McDermott, Toni K Choueiri, Paul J Catalano, Venkata Sabbisetti, Joseph V Bonventre, Phillip M Pierorazio, Nirmish Singla, Paul J Brennan, Rupal S Bhatt
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Wenxin Xu, Valerie Gaborieau, Samuel M Niman, Anush Mukeriya, Xiaowen Liu, Krishna P Maremanda, Ayumi Takakura, David Zaridze, Matthew L Freedman, Wanling Xie, David F McDermott, Toni K Choueiri, Paul J Catalano, Venkata Sabbisetti, Joseph V Bonventre, Phillip M Pierorazio, Nirmish Singla, Paul J Brennan, Rupal S Bhatt
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wenxin Xu, Valerie Gaborieau, Samuel M Niman, Anush Mukeriya, Xiaowen Liu, Krishna P Maremanda, Ayumi Takakura, David Zaridze, Matthew L Freedman, Wanling Xie, David F McDermott, Toni K Choueiri, Paul J Catalano, Venkata Sabbisetti, Joseph V Bonventre, Phillip M Pierorazio, Nirmish Singla, Paul J Brennan, Rupal S Bhatt
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Thomas Denize, Opeyemi A Jagede, Sayed Matar, Nourhan El Ahmar, Destiny J West, Emily Walton, Aseman Sheshdeh Bagheri, Varunika Savla, Yasmin Nabil Laimon, Saurabh Gupta, Sai Vikram Vemula, David A Braun, Kelly P Burke, Paul J Catalano, Gordon J Freeman, Robert J Motzer, Michael B Atkins, David F McDermott, Arlene H Sharpe, Toni K Choueiri, Sabina Signoretti
PD-1 Expression on Intratumoral Regulatory T Cells is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear Cell Renal Cell Carcinoma Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Renee Maria Saliby, Amin H Nassar, Ziad Bakouny, Valisha Shah, Wanling Xie, Ronan Flippot, Thomas Denize, M Harry Kane, Katrine N Madsen, Miriam Ficial, Laure Hirsch, Xiao X Wei, John A Steinarter, Lauren C Harshman, Ulka N Vaishampayan, Mariano Severgnini, David F McDermott, Gwo-Shu Mary Lee, Wenxin Xu, Eliezer Van Allen, Bradley Alexander McGregor, Sabina Signoretti, Toni K Choueiri, Rana R McKay, David A Braun
Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma. Cancer immunology research (2023)
Kathleen M Mahoney, Petra Ross-MacDonald, Long Yuan, Linan Song, Eliseo Veras, Megan Wind-Rotolo, David F McDermott, Frank Stephen Hodi, Toni K Choueiri, Gordon J Freeman
Soluble PD-L1 as an early marker of progressive disease on nivolumab. Journal for immunotherapy of cancer 10 (2) (2022)
Robert J Motzer, Toni K Choueiri, David F McDermott, Thomas Powles, Yann-Alexandre Vano, Saurabh Gupta, Jin Yao, Celine Han, Ron Ammar, Simon Papillon-Cavanagh, Shruti S Saggi, M Brent McHenry, Petra Ross-MacDonald, Megan Wind-Rotolo
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Journal for immunotherapy of cancer 10 (3) (2022)
Michael B Atkins, Opeyemi A Jagede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark N Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael E Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David A Braun, David J Einstein, Paul J Catalano, Hans Hammers
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
David F McDermott, Jae Lyun Lee, Georg Arnold Bjarnason, James M G Larkin, Rustem Airatovich Gafanov, Mark D Kochenderfer, Niels Viggo Jensen, Frede Donskov, Jahangeer Malik, Alexandr Poprach, Scott S Tykodi, Teresa Alonso-Gordoa, Daniel C Cho, Poul F Geertsen, Miguel Angel Climent Duran, Christopher DiSimone, Rachel Kloss Silverman, Rodolfo F Perini, Charles Schloss, Michael B Atkins
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Ziad Bakouny, David A Braun, Sachet A Shukla, Wenting Pan, Xin Gao, Yue Hou, Abdallah Flaifel, Stephen Tang, Alice Bosma-Moody, Meng Xiao He, Natalie I Vokes, Jackson Nyman, Wanling Xie, Amin H Nassar, Sarah Abou Alaiwi, Ronan Flippot, Gabrielle Bouchard, John A Steinharter, Pier Vitale Nuzzo, Miriam Ficial, Miriam Sant'Angelo, Juliet Forman, Jacob E Berchuck, Shaan Dudani, Kevin Bi, Jihye Park, Sabrina Camp, Maura Sticco-Ivins, Laure Hirsch, Sylvan C Baca, Megan Wind-Rotolo, Petra Ross-Macdonald, Maxine Sun, Gwo-Shu Mary Lee, Steven L Chang, Xiao X Wei, Bradley A McGregor, Lauren C Harshman, Giannicola Genovese, Leigh Ellis, Mark Pomerantz, Michelle S Hirsch, Matthew L Freedman, Michael B Atkins, Catherine J Wu, Thai H Ho, W Marston Linehan, David F McDermott, Daniel Y C Heng, Srinivas R Viswanathan, Sabina Signoretti, Eliezer Van Allen, Toni K Choueiri
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. Nature communications 12 (1) (2021)
David F McDermott, Jae Lyun Lee, Marek Ziobro, Cristina Suarez, Przemyslaw Langiewicz, Vsevolod Borisovich Matveev, Pawel Wiechno, Rustem Airatovich Gafanov, Piotr Tomczak, Frederic Pouliot, Frede Donskov, Boris Yakovlevich Alekseev, Sang Joon Shin, Georg Arnold Bjarnason, Daniel Castellano, Rachel Kloss Silverman, Rodolfo F Perini, Charles Schloss, Michael B Atkins
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Toni K Choueiri, Todd M Bauer, Kyriakos P Papadopoulos, Elizabeth R Plimack, Jaime R Merchan, David F McDermott, M Dror Michaelson, Leonard J Appleman, Sanjay Thamake, Rodolfo F Perini, Naseem J Zojwalla, Eric Jonasch
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. Nature medicine 27 (5) (2021)
Kobe C Yuen, Li-Fen Liu, Vinita Gupta, Shravan Madireddi, Shilpa Keerthivasan, Congfen Li, Deepali Rishipathak, Patrick Williams, Edward E Kadel, Hartmut Koeppen, Ying-Jiun Chen, Zora Modrusan, Jane L Grogan, Romain Banchereau, Ning Leng, AnnChristine Thastrom, Xiadong Shen, Kenji Hashimoto, Darren Tayama, Michiel S van der Heijden, Jonathan E Rosenberg, David F McDermott, Thomas Powles, Priti S Hegde, Mahrukh A Huseni, Sanjeev Mariathasan
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nature medicine 26 (5) (2020)
Wenxin Xu, Michael B Atkins, David F McDermott
Checkpoint inhibitor immunotherapy in kidney cancer. Nature reviews. Urology 17 (3) (2020)
Rana R McKay, Bradley Alexander McGregor, Wanling Xie, David A Braun, Xiao Wei, Christos E Kyriakopoulos, Yousef Zakharia, Benjamin L Maughan, Tracy L Rose, Walter M Stadler, David F McDermott, Lauren C Harshman, Toni K Choueiri
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
David A Braun, Yue Hou, Ziad Bakouny, Miriam Ficial, Miriam Sant' Angelo, Juliet Forman, Petra Ross-Macdonald, Ashton C Berger, Opeyemi A Jegede, Liudmilla Elagina, John Steinharter, Maxine Sun, Megan Wind-Rotolo, Jean-Christophe Pignon, Andrew D Cherniack, Lee Lichtenstein, Donna S Neuberg, Paul Catalano, Gordon J Freeman, Arlene H Sharpe, David F McDermott, Eliezer Van Allen, Sabina Signoretti, Catherine J Wu, Sachet A Shukla, Toni K Choueiri
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nature medicine 26 (6) (2020)